chartexchange

NXTC
NextCure, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
6.78USD+1.194%(+0.08)21,403
After-hoursNov 18, 2026 4:32:30 PM EST
6.287USD-7.271%(-0.493)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Beltsville, MD, USA
Previous Close
$6.70
Beta
2.41
52-Week High
$15.74 2025-11-24
52-Week Low
$1.55 2026-06-26
SMA 50
$5.93
SMA 200
$7.49
Avg. Vol 10D
54,353
Avg. Vol 30D
63,909
Avg. Vol 90D
1.51M
Relative Vol
0.33
2.92M
47.6800%
514
Jul 14, 2025 · 1-for-12 (reverse)
NXTC Profile

nextcure, inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. its lead product candidate is nc318, which is in phase 2 clinical trials for the treatment of advanced or metastatic solid tumors. the company is also developing nc410, is a novel immunomedicine designed to block immune suppression mediated by an immune modulator called leukocyte-associated immunoglobulin-like receptor 1. its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules that targets a novel member of the b7-family of immunomodulatory proteins; and an antibody in preclinical development targeting an immune modulator that is expressed in inflamed tissue and the tumor microenvironment in various tumor types. nextcure, inc. has a license agreement with yale university; and a research and development col

NXTC Performance
PeriodPriceDateChangeBeta
1W5.982026-11-11+14.05%-0.361
1M5.672026-10-19+20.28%3.101
3M6.652026-08-18+2.56%2.328
6M9.252026-05-18-26.27%2.941
1Y10.002025-11-18-31.80%2.413
2Y15.482024-11-18-55.94%—
5Y70.562021-11-18-90.33%0.855
NXTC Stock Summary

NextCure, Inc. Common Stock (NASDAQ:NXTC) stock price today is $6.82, and today's volume is 21,405. NXTC is up 1.791% today. The 30 day average volume is 63,909. NXTC market cap is $31.23M with 4.58M shares outstanding.